Combines Extensive Contact Lens & Pharma Experience
Combines Extensive Contact Lens & Pharma Experience
$19 Million
First raise Phase 2 study results – MoxiLensTMClinical trial set-up, management, and data analysis; manufacturing scale-up and validations, Regulatory requirements and submissions
Second raise Phase 3 resultMoxiLensTMClinical trial set-up, management, and data analysis; Clinical trial materials; NDA writing, initial G&A/commercial planning & build
Adding {{itemName}} to cart
Added {{itemName}} to cart